These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 17572198)

  • 1. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.
    Lambert EH; Bolte K; Masson P; Katz AE
    Urology; 2007 Jun; 69(6):1117-20. PubMed ID: 17572198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation.
    Ellis DS; Manny TB; Rewcastle JC
    Urology; 2007 Feb; 69(2):306-10. PubMed ID: 17320669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryosurgical ablation of the prostate: high risk patient outcomes.
    Prepelica KL; Okeke Z; Murphy A; Katz AE
    Cancer; 2005 Apr; 103(8):1625-30. PubMed ID: 15747374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for a "male lumpectomy," a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up.
    Onik G
    Cardiovasc Intervent Radiol; 2008; 31(1):98-106. PubMed ID: 17593431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results.
    Ellis DS; Manny TB; Rewcastle JC
    Urology; 2007 Dec; 70(6 Suppl):9-15. PubMed ID: 18194712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience.
    Koppie TM; Shinohara K; Grossfeld GD; Presti JC; Carroll PR
    J Urol; 1999 Aug; 162(2):427-32. PubMed ID: 10411051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.
    Polascik TJ; Nosnik I; Mayes JM; Mouraviev V
    Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
    Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
    J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cryoablation: prospective analysis comparing high- and low-risk prostate cancer outcomes.
    El Hayek OR; Alfer W; Reggio E; Pompeo AC; Arap S; Lucon AM; Srougi M
    Urol Int; 2008; 81(2):186-90. PubMed ID: 18758217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy.
    Bales GT; Williams MJ; Sinner M; Thisted RA; Chodak GW
    Urology; 1995 Nov; 46(5):676-80. PubMed ID: 7495120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer.
    Donnelly BJ; Saliken JC; Brasher PM; Ernst SD; Rewcastle JC; Lau H; Robinson J; Trpkov K
    Cancer; 2010 Jan; 116(2):323-30. PubMed ID: 19937954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Male lumpectomy": focal therapy for prostate cancer using cryoablation.
    Onik G; Vaughan D; Lotenfoe R; Dineen M; Brady J
    Urology; 2007 Dec; 70(6 Suppl):16-21. PubMed ID: 18194706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience.
    Ghafar MA; Johnson CW; De La Taille A; Benson MC; Bagiella E; Fatal M; Olsson CA; Katz AE
    J Urol; 2001 Oct; 166(4):1333-7; discussion 1337-8. PubMed ID: 11547068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.
    Chung CS; Chen MH; Cullen J; McLeod D; Carroll P; D'Amico AV
    Urology; 2008 Jan; 71(1):136-40. PubMed ID: 18242382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
    Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
    Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients.
    Ismail M; Ahmed S; Kastner C; Davies J
    BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience.
    Siddiqui SA; Mynderse LA; Zincke H; Hoffmann NE; Lobo JR; Wilson TM; Kawashima A; Davis BJ; Blute ML
    Urology; 2007 Jul; 70(1):80-5. PubMed ID: 17656213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?
    Nielsen ME; Makarov DV; Humphreys E; Mangold L; Partin AW; Walsh PC
    Urology; 2008 Aug; 72(2):389-93; discussion 394-5. PubMed ID: 18279937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cryoablation nadir prostate specific antigen and biochemical failure.
    Levy DA; Pisters LL; Jones JS
    J Urol; 2009 Sep; 182(3):931-7. PubMed ID: 19616226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.